Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review
E Martin-Rendon, SJ Brunskill, CJ Hyde… - European heart …, 2008 - academic.oup.com
Aims To provide systematic assessment of the safety and efficacy of autologous bone
marrow-derived stem cell (BMSC) transplantation in acute myocardial infarction (AMI) based on …
marrow-derived stem cell (BMSC) transplantation in acute myocardial infarction (AMI) based on …
[HTML][HTML] Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain
MA Benson, SE Newey, E Martin-Rendon… - Journal of Biological …, 2001 - ASBMB
The dystrophin-associated protein complex (DPC) is required for the maintenance of
muscle integrity during the mechanical stresses of contraction and relaxation. In addition to …
muscle integrity during the mechanical stresses of contraction and relaxation. In addition to …
Stem cell treatment for acute myocardial infarction
Background Stem cell therapy offers a promising approach to the regeneration of damaged
vascular and cardiac tissue after acute myocardial infarction (AMI). This has resulted in …
vascular and cardiac tissue after acute myocardial infarction (AMI). This has resulted in …
Stem cell therapy for chronic ischaemic heart disease and congestive heart failure
…, DP Taggart, E Martin‐Rendon - Cochrane Database …, 2016 - cochranelibrary.com
Background A promising approach to the treatment of chronic ischaemic heart disease and
congestive heart failure is the use of stem cells. The last decade has seen a plethora of …
congestive heart failure is the use of stem cells. The last decade has seen a plethora of …
Multicistronic lentiviral vector-mediated striatal gene transfer of aromatic L-amino acid decarboxylase, tyrosine hydroxylase, and GTP cyclohydrolase I induces …
M Azzouz, E Martin-Rendon, RD Barber… - Journal of …, 2002 - Soc Neuroscience
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the selective
loss of dopaminergic neurons in the substantia nigra. This loss leads to complete dopamine …
loss of dopaminergic neurons in the substantia nigra. This loss leads to complete dopamine …
5‐Azacytidine‐treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro …
E Martin‐Rendon, D Sweeney, F Lu… - Vox …, 2008 - Wiley Online Library
Background and Objectives Mesenchymal stem/progenitor cells (MSCs) are multipotent
progenitors that differentiate into such lineages as bone, fat, cartilage and stromal cells that …
progenitors that differentiate into such lineages as bone, fat, cartilage and stromal cells that …
Meta-analysis of cell therapy trials for patients with heart failure
… Two reviewers (SA Fisher, E. Martin-Rendon) independently screened the titles and
abstracts of all remaining references against the full eligibility criteria. The full text of articles was …
abstracts of all remaining references against the full eligibility criteria. The full text of articles was …
Transcriptional Profiling of Human Cord Blood CD133+ and Cultured Bone Marrow Mesenchymal Stem Cells in Response to Hypoxia
E Martin-Rendon, SJM Hale, D Ryan, D Baban… - Stem …, 2007 - academic.oup.com
Umbilical cord blood (UCB) and bone marrow (BM)-derived stem and progenitor cells
possess two characteristics required for successful tissue regeneration: extensive proliferative …
possess two characteristics required for successful tissue regeneration: extensive proliferative …
Stem cell treatment for acute myocardial infarction
Background Cell transplantation offers a potential therapeutic approach to the repair and
regeneration of damaged vascular and cardiac tissue after acute myocardial infarction (AMI). …
regeneration of damaged vascular and cardiac tissue after acute myocardial infarction (AMI). …
The emerging roles of TCF4 in disease and development
…, MJ Hill, AJ Quantock, E Martin-Rendon… - Trends in molecular …, 2014 - cell.com
Genome-wide association studies have identified common variants in transcription factor 4 (TCF4)
as susceptibility loci for schizophrenia, Fuchs' endothelial corneal dystrophy, and …
as susceptibility loci for schizophrenia, Fuchs' endothelial corneal dystrophy, and …